TRPM6 and TRPM7 are distinct from all other ion channels in that they are composed of linked channel and protein kinase domains. Recent studies demonstrate that these 'chanzymes' are essential for Mg 2+ homeostasis, which is critical for human health and cell viability.
The discovery that TRPM7 conducts Mg 2+ and is required for cell viability suggested that the TRPM7-dependent Mg 2+ influx is essential. But TRPM7 is not a Mg 2+ -selective channel; rather, it conducts Ca 2+ , as well as trace and toxic metals such as Zn 2+ , Ni 2+ , Ba 2+ and Co 2+ [5, 6, 10] . Nevertheless, strong support for the view that TRPM7 functions in Mg 2+ homeostasis has come from the recent demonstration by Schmitz et al. [11] that supplementing the cell-culture medium with Mg 2+ rescues the growth arrest and cell lethality that otherwise results from inducibly knocking out TRPM7 expression. Addition of high levels of other cations is ineffective in substituting for the loss of TRPM7. The ability of supplemental Mg 2+ to complement the lack of TRPM7 is presumably the result of increased Mg 2+ entry through the slow and passive mode of Mg 2+ influx.
The demonstration that TRPM7 is critical for Mg 2+ homeostasis raises the possibility that mutation of TRPM7 may cause human disease as a result of reduced cellular Mg 2+ levels. While such an association has not been established for TRPM7, it has recently been shown that mutations in the highly related chanzyme TRPM6 cause hypomagnesemia with secondary hypocalcemia [12, 13] . Individuals with this disease display seizures and muscle spasms during infancy, which may lead to death if untreated. Interestingly, the symptoms associated with TRPM6 mutations are ameliorated by supplementation with high doses of Mg 2+ , consistent with the observation that the cell lethality caused by knocking out TRPM7 is suppressed by addition of high levels of Mg 2+ to the culture medium.
Whether TRPM6 and TRPM7 functionally interact in vivo has not been addressed, but this seems quite plausible. Previous studies [14] [15] [16] of Drosophila and mammalian TRPC proteins established that TRP channels are capable of forming heteromultimeric assemblies, which may alter the biophysical properties of the channels. Such interactions are favored among those channels that are the most related [15] . While TRPM7 is expressed widely, its RNA is found at relatively high levels in the kidneys [6] , a tissue that also expresses comparatively high concentrations of TRPM6 RNA [12, 13] .
A key question concerns the nature of the mechanisms underlying the activation and regulation of TRPM7. In particular, what is the function of the atypical protein kinase domain? According to one report [6] , activation of the TRPM7 channel requires ATP, a functional kinase domain and autophosphorylation. It has also been reported that the TRPM7 current is suppressed by increasing concentrations of Mg 2+ , leading to the suggestion that the stimulatory effect of ATP is a consequence of a drop in free Mg 2+ [5] . Several recent observations suggest that the kinase domain is not required for activation. As the free Mg 2+ levels are increased, the kinase activity increases, but the channel activity is diminished rather than increased [11] . Furthermore, Schmitz et al. [11] found that TRPM7 channels containing point mutations that disrupt the kinase activity are still active, though they render the channel less sensitive to Mg 2+ inhibition. Further evidence that these kinase-defective mutants retain channel function in vivo is that their introduction into TRPM7-deficient cells fully rescues the growth arrest and lethality. Conversely, a truncated form of TRPM7, lacking the kinase domain, displays an increased sensitivity to Mg 2+ suppression and fails to complement the cell lethality resulting from knockout of TRPM7. However, deletion of the kinase domain does not prevent activation. The basis for the divergent effects on Mg 2+ sensitivity resulting from point mutations in or deletion of the kinase domain is unresolved. Nevertheless, the work of Schmitz et al. [11] indicates that the kinase domain is not required for channel activation, but influences sensitivity of the channel to Mg 2+ inhibition.
In addition to Mg 2+ inhibition, TRPM7 has also been shown to be inactivated by hydrolysis of the phosphoinositide lipid PIP 2 [17] . This latter finding is intriguing, given that TRPM7 was discovered by one group on the basis of binding to PLC, which cleaves PIP 2 [6] . Thus, the question arises as to whether there is a link between the two seemingly disparate modes of channel inhibition: an increase in Mg 2+ and hydrolysis of PIP 2 . An attractive possibility, which needs to be investigated, is that Mg 2+ activates the PLC that associates with TRPM7. Such a possibility is strengthened by a study in B lymphocytes demonstrating the presence of phosphoinositide-specific PLC which is activated as the Mg 2+ concentration is raised from 30 to 1000 µ µM [18] . While a Mg 2+ -activated PLC has not been described in other cell types, it may be present in a variety of other cell types including other lymphoid-derived cell lines, such as Jurkat T cells and rat basophilic leukemia cells. These latter cell lines are attractive candidates for expressing a Mg 2+ -activated PLC, as they contain an endogenous TRPM7-like current, referred to as a Mg 2+ -inhibited cation channel (MIC) [19, 20] .
Many additional questions remain concerning TRPM6 and TRPM7. The in vivo substrate for their kinase domains remains to be identified. Furthermore, the physiological mode of activation of TRPM7 is still unresolved. At present, the ion selectivity or any other biophysical properties of TRPM6-dependent currents have not been described. It is intriguing to speculate that, if TRPM6 conducts toxic metals as effectively as TRPM7, those individuals with TRPM6 mutations may display an elevated resistance to exposure to toxic metals such as Ni 2+ and Co 2+ . 
